At the recent annual shareholders' meeting of Huahai Pharmaceutical (600521), two temporary proposals introduced by Zhou Minghua, the former general manager and second-largest shareholder, were rejected. The proposals, which included a request to revise Zhou’s previous promises to shareholders and a pre-plan for the 2007 profit distribution, failed to gain enough support. The current chairman and CEO, Chen Baohua, reaffirmed the company's three-year commitment to an average annual growth rate of 25%, emphasizing that this target remains unchanged.
The voting results showed that only a small fraction of shareholders supported the proposals. For the first proposal, 5,585,348 votes were in favor (6.75%), while 8,236,759 voted against (9.95%), and 68,918,903 abstained (83.29%). For the second proposal, 53,469,603 shares supported it (39.90%), 10,804,122 opposed it (8.06%), and 6,731,003 abstained (52.04%). Notably, Chen Baohua did not vote on either proposal.
During the meeting, shareholders raised concerns about the ongoing tension between Zhou and the board. Zhou explained his reasons for submitting the proposals, stating he had no intention of undermining the company or challenging its leadership. He hinted that if the proposals failed, he might adjust his stake in the company—either reducing or increasing it, or even seeking control again.
Some investors expressed worry that Zhou’s rejection could lead to further actions, creating instability for the company. They emphasized the need for both sides to find a balanced solution to avoid long-term damage. One analyst suggested that all shareholders should support the current management to fulfill their commitments before addressing existing issues, as continued conflict would be detrimental to everyone.
Chen Baohua clarified that his decision-making is based on what benefits the company's future and its shareholders. While he acknowledged Zhou’s career ambitions in the pharmaceutical industry, he stressed that Huahai has grown strong and is prepared to face competition.
Reiterating his earlier commitments, Chen stated that the company will never engage in related-party transactions, avoid speculative investments, and ensure a minimum 25% annual growth over the next three years. After the meeting, he shared his vision for the company’s development from 2008 to 2010, highlighting plans to enhance R&D, sales systems, and industrial chains. The goal is to achieve structural optimization, scale effects, and sustainable growth.
Looking ahead, the company aims to focus on two major industrial chains—raw materials and finished drugs—as well as two R&D and sales systems. By leveraging synergies and improving efficiency, Huahai hopes to strengthen its market position and boost profitability. The company is confident that these strategic moves will drive rapid development in the coming years.
Scouring Agents
Before dyeing and printing textiles need to go through a certain scouring process to remove impurities and oil stains from the fabric. This scouring process is often referred to as scouring. And in the refining added with various types of infiltration, emulsification, washing, dispersion, wetting function of chemical additives, is called the scouring agent.
Scouring agent is to use chemical and physical methods to remove cotton, wool, hemp, silk and synthetic fiber and other kinds of textile natural impurities, dirt and weaving slurry process called scouring. Therefore, broadly speaking, in the process of refining added acid, alkali, oxidant, reducing agent and all kinds of surfactants and other chemicals can be called scouring agent.
Scouring agents, bleaching agents, Desizing agents
Dymatic Chemicals, Inc. , https://www.dymachem.com